Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout

CompletedOBSERVATIONAL
Enrollment

188

Participants

Timeline

Start Date

November 15, 2011

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Refractory Chronic Gout
Interventions
BIOLOGICAL

Pegloticase

Pegloticase 8 mg intravenous every 2 weeks

Trial Locations (67)

11787

Rheumatology Associates of Long Island, Smithtown

16602

Keystone Pain Institute, Ilumina Clinical Associates, Altoona

17033

Penn State Milton S. Hershey Medical Center, Hershey

20060

Howard University Hospital, Washington D.C.

20109

Arthritis & Osteoporosis Center of North Virginia, Manassas

20422

Washington DC Veteran's Affairs Medical Center, Washington D.C.

20902

The Center for Rheumatology and Bone Research, Wheaton

21740

Klein & Associates MD, PA., Hagerstown

22205

Arthritis Clinic of Northern Virginia, P.C., Arlington

23502

Sentara Rheumatology Specialists, Norfolk

26301

Mountain State Clinical Research, Clarksburg

27330

Specialty Medical Clinic and Research Center, Sanford

27617

Shanahan Rheumatology and Immunotherapy, PLLC, Raleigh

27710

Duke University Medical Center, Durham

27832

Physicians East, PA, Greenville

28025

NorthEast Rheumatology, Concord

29118

Acme Research L.L.C., Orangeburg

29406

Low Country Rheumatology, Charleston

30281

Arthritis Research & Treatment Center, Stockbridge

30701

Global Research Partners & Consultants, Inc., Calhoun

33026

Family Clinical Trials, LLC, Pembroke Pines

33174

A & O Research Center, Miami

33458

Science and Research Institute, Inc, Jupiter

33511

Bay Area Arthritis and Osteoporosis, Brandon

33604

Jedidiah Clinical Research, Tampa

33614

Midtown Medical Center, Tampa

33761

Countryside Arthritis Center, Clearwater

34684

Arthritis Research of Florida, Inc., Palm Harbor

35205

Rheumatology Associates, PC, Birmingham

35294

UAB Rheumatology, Birmingham

35801

Saadat Ansari, MD, LLC, Huntsville

38119

Ramesh C. Gupta, M.D., Memphis

40353

Central Kentucky Research Associates of Kentucky, Mount Sterling

42303

Research Integrity, LLC, Owensboro

45662

Southern Ohio Rheumatology, Portsmouth

46227

Diagnostic Rheumatology and Research PC, Indianapolis

48081

Shores Rheumatology, PC, Saint Clair Shores

48723

Caro Health Plaza, Caro

48910

Justus J. Fiechtner, MD, PC, Lansing

49525

Infusion Associates, Grand Rapids

52401

Physicians' Clinic of Iowa, P.C., Cedar Rapids

53217

Rheumatic Disease Center, LLP, Glendale

55121

Saint Paul Rheumatology, PA, Eagan

60637

University of Chicago Medical Center, Chicago

64114

Kansas City Internal Medicine, Kansas City

70535

Horizon Research Group of Opelousas, LLC, Eunice

71203

Arthritis and Diabetes Clinic, Inc., Monroe

77004

Diagnostic Clinic of Houston, Houston

Rheumatic Disease Clinical Research Center, Houston

78731

Austin Regional Clinic, Austin

79902

Dr. Raj Marwah, El Paso

80218

Denver Nephrologists, PC, Denver

89118

Arthritis Medical Clinic, Las Vegas

90045

Pacific Arthritis Care Center, Los Angeles

90712

Advanced Medical Research, LLC, Lakewood

91723

Medvin Clinical Research, Covina

91754

R Srinivasan, MD, Inc, Monterey Park

92064

Alliance Clinical Research, Poway

92563

Brigid Freyne, MD, Inc, Murrieta

92653

Alliance Clinical Research, LLC, Laguna Hills

99336

Apex Clinical Research, Kennewick

06611

New England Research Associates, LLC, Trumbull

20889-5630

Walter Reed National Military Medical Center, Bethesda

01605

Clinical Pharmacology Study Groups, Worcester

Reliant Medical Group, Inc., Worcester

48109-5422

University of Michigan Health System, Ann Arbor

07666

Rheumatology Associates of North Jersey, Teaneck

All Listed Sponsors
lead

Horizon Pharma Rheumatology LLC

INDUSTRY

NCT01466166 - Observational Study of the Use of Pegloticase (KRYSTEXXA®) in Refractory Chronic Gout | Biotech Hunter | Biotech Hunter